Sirtuins-mediators of maternal obesity-induced complications in offspring?
- Publication Type:
- Journal Article
- Citation:
- FASEB Journal, 2016, 30 (4), pp. 1383 - 1390
- Issue Date:
- 2016-04-01
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
| Sirtuin review_FASEB J_accepted.docx | Accepted Manuscript Version | 429.49 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
© 2016 FASEB. Obesity is a complex metabolic disease, attributed to diverse and interactive genetic and environmental factors. The associated health consequences of obesity are pleiotropic, with individuals being more susceptible to chronic diseases such as type 2 diabetes mellitus, hypertension, and lipotoxicity-related chronic diseases. The contribution of maternal obesity to the offspring's predisposition to both obesity and its complications is increasingly recognized. Understanding the mechanisms underlying these "transmissible" effects is critical to develop therapeutic interventions to reduce the risk for "programmed" obesity. Sirtuins (SIRTs), particularly SIRT1 and SIRT3, are NAD+-dependent deacetylases that regulate metabolic balance and stress responses in both central and peripheral tissues, of which dysregulation is a well-established mediator for the development and effects of obesity. Nevertheless, their implication in the transmissible effects of maternal obesity across generations remains largely elusive. In this review, we examine multiple pathways and systems that are likely to mediate such effects, with particular emphasis on the role of SIRTs.
Please use this identifier to cite or link to this item: